Mach7 Technologies Limited

ASX:M7T Stock Report

Market Cap: AU$79.6m

Mach7 Technologies Valuation

Is M7T undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of M7T when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: M7T (A$0.33) is trading above our estimate of fair value (A$0.14)

Significantly Below Fair Value: M7T is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for M7T?

Key metric: As M7T is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for M7T. This is calculated by dividing M7T's market cap by their current revenue.
What is M7T's PS Ratio?
PS Ratio2.7x
SalesAU$29.13m
Market CapAU$79.61m

Price to Sales Ratio vs Peers

How does M7T's PS Ratio compare to its peers?

The above table shows the PS ratio for M7T vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average13.6x
ALC Alcidion Group
2.2x8.2%AU$80.6m
BMT Beamtree Holdings
2.9x21.9%AU$76.8m
CGS Cogstate
2.7x10.9%AU$203.3m
ENL Enlitic
46.7x140.1%AU$34.4m
M7T Mach7 Technologies
2.7x18.1%AU$79.6m

Price-To-Sales vs Peers: M7T is good value based on its Price-To-Sales Ratio (2.7x) compared to the peer average (13.6x).

Price to Sales Ratio vs Industry

How does M7T's PS Ratio compare vs other companies in the AU Healthcare Services Industry?

7 CompaniesPrice / SalesEstimated GrowthMarket Cap
MDR MedAdvisor
1.2x13.4%US$97.83m
DOC Doctor Care Anywhere Group
0.3x6.3%US$15.99m
IME ImExHS
0.7x20.5%US$9.94m
VFX Visionflex Group
1.3xn/aUS$5.45m
M7T 2.7xIndustry Avg. 3.4xNo. of Companies7PS0816243240+
7 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: M7T is good value based on its Price-To-Sales Ratio (2.7x) compared to the Global Healthcare Services industry average (3.4x).

Price to Sales Ratio vs Fair Ratio

What is M7T's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

M7T PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio2.7x
Fair PS Ratio0.8x

Price-To-Sales vs Fair Ratio: M7T is expensive based on its Price-To-Sales Ratio (2.7x) compared to the estimated Fair Price-To-Sales Ratio (0.8x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst M7T forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentAU$0.33
AU$1.16
+257.8%
14.0%AU$1.36AU$0.95n/a5
Dec ’25AU$0.36
AU$1.16
+218.6%
14.0%AU$1.36AU$0.95n/a5
Nov ’25AU$0.42
AU$1.16
+176.9%
14.0%AU$1.36AU$0.95n/a5
Oct ’25AU$0.56
AU$1.13
+103.4%
14.6%AU$1.36AU$0.95n/a4
Sep ’25AU$0.53
AU$1.13
+113.0%
14.6%AU$1.36AU$0.95n/a4
Aug ’25AU$0.61
AU$1.23
+99.5%
16.3%AU$1.56AU$1.05n/a4
Jul ’25AU$0.64
AU$1.24
+95.6%
14.6%AU$1.56AU$1.05n/a5
Jun ’25AU$0.66
AU$1.24
+89.6%
14.6%AU$1.56AU$1.05n/a5
May ’25AU$0.71
AU$1.24
+74.9%
14.6%AU$1.56AU$1.05n/a5
Apr ’25AU$0.71
AU$1.24
+73.6%
14.6%AU$1.56AU$1.05n/a5
Mar ’25AU$0.69
AU$1.24
+78.7%
14.5%AU$1.56AU$1.05n/a5
Feb ’25AU$0.71
AU$1.22
+71.0%
15.6%AU$1.56AU$1.05n/a5
Jan ’25AU$0.79
AU$1.23
+55.4%
14.4%AU$1.54AU$1.05n/a5
Dec ’24AU$0.72
AU$1.27
+75.5%
13.4%AU$1.54AU$1.10AU$0.364
Nov ’24AU$0.69
AU$1.33
+91.4%
12.1%AU$1.54AU$1.15AU$0.423
Oct ’24AU$0.80
AU$1.42
+78.6%
8.5%AU$1.54AU$1.30AU$0.562
Sep ’24AU$0.78
AU$1.42
+82.1%
8.5%AU$1.54AU$1.30AU$0.532
Aug ’24AU$0.85
AU$1.48
+72.5%
11.9%AU$1.65AU$1.30AU$0.612
Jul ’24AU$0.62
AU$1.32
+113.2%
1.7%AU$1.34AU$1.30AU$0.642
Jun ’24AU$0.56
AU$1.32
+137.8%
1.5%AU$1.34AU$1.30AU$0.662
May ’24AU$0.68
AU$1.32
+95.6%
1.5%AU$1.34AU$1.30AU$0.712
Apr ’24AU$0.60
AU$1.27
+112.0%
5.7%AU$1.34AU$1.20AU$0.712
Mar ’24AU$0.60
AU$1.27
+110.3%
5.7%AU$1.34AU$1.20AU$0.692
Feb ’24AU$0.72
AU$1.27
+76.5%
5.5%AU$1.34AU$1.20AU$0.712
Jan ’24AU$0.57
AU$1.27
+123.2%
5.7%AU$1.34AU$1.20AU$0.792
Dec ’23AU$0.58
AU$1.27
+117.5%
5.7%AU$1.34AU$1.20AU$0.722

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/19 08:04
End of Day Share Price 2024/12/19 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Mach7 Technologies Limited is covered by 11 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Scott PowerCGS International
ZheWei SimJefferies LLC
David LowJ.P. Morgan